Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial-Reference-Cited by-同舟云学术

Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial

Published:2005-03-22 Issue:6 Volume:84 Page:376-382
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Thomas Xavier,Elhamri Mohamed,Chelghoum Youcef,Reman Oumedaly,Arnaud Philippe,Raffoux Emmanuel,Le Quoc-Hung,Tavernier Emmanuelle,Dombret Hervé,Michallet Mauricette

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-005-1037-1.pdf

Reference34 articles.

1. Estey EH, Keating MJ, McCredie KB, Bodey GP, Freireich EJ (1983) Phase II trial of mitoxantrone in refractory acute leukemia. Cancer Treat Rep 67:389–390

2. Brito-Babapulle F, Catovsky D, Slocombe G, Newland AC, Marcus RE, Goldman JM, Galton DAG (1987) Phase II study of mitoxantrone and cytarabine in acute myeloid leukemia. Cancer Treat Rep 71:161–163

3. Fujimoto S, Ogawa M (1982) Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics. Cancer Chemother Pharmacol 8:157–161

4. Henderson BM, Dougherty WJ, James VC, Tilley LP, Noble JF (1982) Safety assessment of a new anticancer compound, mitoxantrone, in Beagle dogs; comparison with doxorubicin. I. Clinical observations. Cancer Treat Rep 66:1139–1143

5. Zbinden G, Beilstein AK (1982) Comparison of cardiotoxicity of two anthracenediones and doxorubicin in rats. Toxicol Lett 11:289–297

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitoxantrone as a contributing factor in medication-related osteonecrosis of the jaws;International Journal of Oral and Maxillofacial Surgery;2016-03

2. Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments;Journal of Chemistry;2016

3. Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML);Annals of Hematology;2013-10-23

4. Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia;Leukemia Research;2009-04

5. The role of timed sequential chemotherapy in adult acute myelogenous leukemia;Current Hematologic Malignancy Reports;2008-04